Gastrointestinal Asia-Pacific Industry Pipeline Analysis 2019

1
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet
NeedbyGBI Research

• Explore all reports for  Gastrointestinal
  Therapeutics market
• _at_
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/therapeutics/gastrointestinal
  -therapeutics .

2
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet Need

• Research Report, the leading business
  intelligence provider, has released its latest
  research, Gastrointestinal Therapeutics in
  Asia-Pacific Markets to 2019 Strong Potential for
  Pipeline Biologics on Account of High Regional
  Unmet Need, which provides insights into three
  therapeutic indications in gastrointestinal
  disorders in Asia-Pacific (APAC) markets of
  India, China, Japan and Australia. The report
  provides an in-depth analysis of the therapeutic
  indications of gastrointestinal disorders, namely
  Irritable Bowel Syndrome (IBS), Ulcerative
  Colitis (UC) and Crohns Disease (CD). The report
  provides an estimation of market size for 2012,
  along with market forecast until 2019. It also
  covers disease epidemiology, treatment
  algorithms, treatment patterns, in-depth analysis
  of the pipeline, and deal analysis for these
  three gastrointestinal indications.
• Scope
• Disease overview and treatment usage patterns
• Market size and forecast for IBS, UC and CD in
  APAC market from 2012 to 2019
• Major marketed products for the indications types
  covered
• Inquire for Discount _at_
• http//www.rnrmarketresearch.com/contacts/discount
  ?rname148415 .

3
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet Need

• In-depth pipeline analysis for IBS, UC and CD
• Key drivers and restraints that have had and are
  expected to have a significant impact upon the
  market
• Key licensing and co-development agreements in
  the gastrointestinal therapeutics market
• Reasons to buy
• Align your product portfolio to the markets with
  high growth potential
• Develop market entry and expansion strategies by
  identifying the potential regions and therapeutic
  segments poised for strong growth
• Devise a more effectively tailored country
  strategy through the understanding of key drivers
  and barriers in the gastrointestinal therapeutics
  market
• Develop key strategic initiatives based upon an
  understanding of key focus areas and leading
  companies
• Accelerate and strengthen your market position by
  identifying key companies for mergers,
  acquisitions and strategic partnerships
• Complete Report Available _at_
• http//www.rnrmarketresearch.com/gastrointestinal-
  therapeutics-in-asia-pacific-markets-to-2019-stron
  g-potential-for-pipeline-biologics-on-account-of-h
  igh-regional-unmet-need-market-report.html .

4
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet Need

• Table of Contents
• 1 Table of Contents 61.1 List of Tables 91.2
  List of Figures 10
• 2 Gastrointestinal Therapeutics in Asia-Pacific
  Market - Introduction 112.1 Irritable Bowel
  Syndrome 112.1.1 Classification 112.1.2
  Symptoms 112.1.3 Etiology 112.1.4
  Pathophysiology 122.1.5 Diagnosis 122.1.6
  Epidemiology 142.1.7 Prognosis 142.1.8
  Treatment Options 142.2 Ulcerative Colitis 15
• Buy a copy of report _at_
• http//www.rnrmarketresearch.com/contacts/purchase
  ?rname148415 .

5
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet Need

• 3 Gastrointestinal Therapeutics in Asia-Pacific
  Market - Marketed Products (Global) 263.1
  Irritable Bowel Syndrome 263.2 Ulcerative
  Colitis 263.3 Crohn's Disease 263.4 Key
  Marketed Products 273.4.1 Amitiza 273.4.2
  Humira 283.4.3 Remicade 293.4.4 Simponi
  303.4.5 Cimzia 313.4.6 Tysabri 32
• 4 Gastrointestinal Therapeutics in Asia-Pacific
  Market - Pipeline Analysis 34
• Request Sample copy of this report _at_
  http//www.rnrmarketresearch.com/contacts/discount
  ?rname148415 .

6
Gastrointestinal Therapeutics in Asia-Pacific
Markets to 2019 Strong Potential for Pipeline
Biologics on Account of High Regional Unmet Need

• For more details contact Mr. Priyank Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.